Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Go-Ahead for Anti-AIDS Gel Trials

August 4, 2003

A note from TheBody.com: The field of medicine is constantly evolving. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

An Australian company has won FDA approval to begin human trials for its microbicide gel. In macaque monkey trials, a single application of VivaGel was 100 percent effective against the monkey version of HIV and the animal versions of genital herpes and chlamydia. Melbourne-based Starpharma will begin phase one human trials of VivaGel by the end of this year. If human trials are successful, the gel will be targeted to women in poorer nations, giving them cheaper, easier control over HIV prevention. A prescription-only gel could be available in three years' time. It would take another two years to produce an over-the-counter version. Countries such as Myanmar and Papua New Guinea face looming AIDS crises similar to the epidemic in Africa due to a lack of preventive measures. At the end of 2002, 42 million people worldwide were HIV-infected; estimates say by 2010, 45 million more people will have HIV.

Back to other news for August 4, 2003

Adapted from:
CNN.com
07.31.03; Grant Holloway

A note from TheBody.com: The field of medicine is constantly evolving. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News and Research on Microbicides


Advertisement